chr6-31025912-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001395414.1(MUC22):c.481G>T(p.Ala161Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000261 in 1,532,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395414.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC22 | NM_001395414.1 | c.481G>T | p.Ala161Ser | missense_variant | 2/4 | ENST00000561890.1 | NP_001382343.1 | |
MUC22 | NM_001318484.1 | c.490G>T | p.Ala164Ser | missense_variant | 3/5 | NP_001305413.1 | ||
MUC22 | NM_001198815.1 | c.481G>T | p.Ala161Ser | missense_variant | 3/5 | NP_001185744.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC22 | ENST00000561890.1 | c.481G>T | p.Ala161Ser | missense_variant | 2/4 | 2 | NM_001395414.1 | ENSP00000455906 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000201 AC: 3AN: 149022Hom.: 0 Cov.: 32
GnomAD4 exome AF: 7.23e-7 AC: 1AN: 1383356Hom.: 0 Cov.: 86 AF XY: 0.00000147 AC XY: 1AN XY: 682538
GnomAD4 genome AF: 0.0000201 AC: 3AN: 149022Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 1AN XY: 72724
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.481G>T (p.A161S) alteration is located in exon 3 (coding exon 2) of the MUC22 gene. This alteration results from a G to T substitution at nucleotide position 481, causing the alanine (A) at amino acid position 161 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at